330 related articles for article (PubMed ID: 8677550)
1. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
Ratner MIa; Fedorova ND
Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
[TBL] [Abstract][Full Text] [Related]
2. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
[TBL] [Abstract][Full Text] [Related]
3. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
[TBL] [Abstract][Full Text] [Related]
4. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
[TBL] [Abstract][Full Text] [Related]
5. [The therapy of mesangiocapillary glomerulonephritis].
Ratner MIa; Fedorova ND; Biriukova LS; Makurov AI
Ter Arkh; 1995; 67(8):10-2. PubMed ID: 7482319
[TBL] [Abstract][Full Text] [Related]
6. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa; Biriukova LS; Makurov AI
Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
[No Abstract] [Full Text] [Related]
8. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
[TBL] [Abstract][Full Text] [Related]
9. [Some problems of the therapy of chronic glomerulonephritis].
Riabov SI; Stavskaia VV
Ter Arkh; 1987; 59(11):66-71. PubMed ID: 3441869
[TBL] [Abstract][Full Text] [Related]
10. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
[TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
Riabov SI; Stavskaia VV; Sheveleva LA
Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
[TBL] [Abstract][Full Text] [Related]
13. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
Ardiles LG; Mezzano SA
Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
[TBL] [Abstract][Full Text] [Related]
16. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
18. [The importance of the clinical classification of chronic glomerulonephritis for the prognosis of its progression and of the efficacy of therapy].
Ratner MIa; Serov VV; Stenina IN; Fedorova ND; Shumakov VI
Ter Arkh; 1996; 68(6):10-3. PubMed ID: 8771673
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
Belovezhdov N
Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
[TBL] [Abstract][Full Text] [Related]
20. [The dependence of the progression of chronic glomerulonephritis on the clinical and morphological types of glomerulonephritis and on the tubulointerstitial changes].
Ratner MIa; Fedorova ND
Urol Nefrol (Mosk); 1998; (2):22-4. PubMed ID: 9577698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
